Hepatitis C Virus
Studies from the United States and Israel add new findings to hepatitis C virus body of knowledge
Published in Hepatitis Weekly, October 30th, 2006
Study 1: A recent study from the United States has reported on the monitoring of viral kinetics during treatment of chronic hepatitis C virus (HCV).
"HCV is a major cause of chronic hepatitis and hepatic fibrosis, and chronic infection can frequently progress to cirrhosis, end-stage liver disease and hepatocellular carcinoma. Treatment with pegylated interferons (INFs) plus ribavirin has been shown to be more effective than pegylated INFs alone or standard INFs with or without ribavirin," wrote J.E. Laydenalmer and colleagues, University of Illinois.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2006-10-30)
More Articles from Hepatitis Weekly
- Apoptosis
Virus-induced hepatocyte apoptosis is mediated by a transcription factor - Hepatitis B Virus
Hepatitis B virus lamivudine-resistant mutations rapidly detected - Hepatitis B Virus
Hepatitis B virus multi-drug resistance evolves during sequential therapy - Hepatitis B Virus
Hepatitis B virus residue phosphorylation facilitates core assembly - Hepatitis C Virus
Hepatitis C virus treatment response predicted - Hepatitis B Virus
New findings from University of Hong Kong, Department of Medicine in the area of hepatitis b virus published - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
